Influence of Herbal Infusion on Metabolic Syndrome
1 other identifier
interventional
330
1 country
1
Brief Summary
After taking written informed consent patients, the selected participants were divided into control and experimental group randomly.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 7, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 11, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
November 20, 2021
CompletedFirst Submitted
Initial submission to the registry
December 6, 2024
CompletedFirst Posted
Study publicly available on registry
December 11, 2024
CompletedDecember 16, 2024
December 1, 2024
4 months
December 6, 2024
December 11, 2024
Conditions
Outcome Measures
Primary Outcomes (5)
Waist Circumference
Normal range of waist circumference in men should be less than 40 inches and in women it should be less than 35 inches. Change in the waist circumference will be monitored during the trial. \>102 cm ( \>40 in ) \>88 cm ( \>35 in )
60 days
Serum Triglyceride Level
Change in serum Triglyceride Level were monitored before and after the trial
60 days
Serum HDL- Cholesterol Level
Change in Levels were monitored before and after the trial
60 days
Blood Pressure (Systolic and Diastolic)
Change in readings were monitored before and after the trial
60 days
Fasting Glucose Level
Change in readings were monitored before and after the trial
60 days
Study Arms (5)
Conventional therapy group
ACTIVE COMPARATORControl group on Carbohydrate Controlled Diet with conventional therapy
Cumin tea group
EXPERIMENTALIntervention with Carbohydrate Controlled Diet along with Cumin Seeds Tea
Ginger Tea Group
EXPERIMENTALIntervention with Carbohydrate Controlled Diet along with Ginger Tea
Lemon Peel Tea Group
EXPERIMENTALIntervention with Carbohydrate Controlled Diet along with Lemon Peel Tea
Functional tea Group
EXPERIMENTAL: Intervention with Carbohydrate Controlled Diet along with Functional Tea
Interventions
The preparation involved boiling 200 ml of water with 2 grams of cumin seeds. Patients were instructed to consume/ have tea twice a day i.e. in mid-morning and in the evening without sugar respectively.
The preparation involved boiling 200 ml of water with 2 grams of ginger. Patients were instructed to consume/ have tea twice a day i.e. in mid-morning and in the evening without sugar respectively.
The preparation involved boiling 200 ml of water with 2 grams of lemon peel. Patients were instructed to consume/ have tea twice a day i.e. in mid-morning and in the evening without sugar respectively.
The preparation involved boiling 200 ml of water with 2 grams of functional tisane (0.6 g cumin seeds, 0.6 g ginger, and 0.6 g lemon peel) Patients were instructed to consume/ have tea twice a day i.e. in mid-morning and in the evening without sugar respectively.
A carbohydrate-controlled diet focuses on limiting refined carbohydrates and sugars and total carbohydrate restriction to 50-70gm per major meal.
Eligibility Criteria
You may qualify if:
- Metabolic syndrome patients either gender of 18 to 60 years will be included.
- Patients will be recruited on the basis of ATP III criteria
- Patients having any body mass index with confirmed diagnosis of Metabolic Syndrome and no use of any dietary supplement or no adherence to special diets at least one month prior to baseline
You may not qualify if:
- Individuals with the following conditions will not be included as participants
- Genetically obese individuals
- Patients already on lipid lower drugs according to recommendation of physicians
- Patients taking any nutritional supplement
- Allergy to any drugs or specific foods
- Breastfeeding mothers
- Pregnant females
- Patients with any other medical history (renal diseases, infections, liver disorders, cardiovascular diseases)
- Patients receiving weight loss drugs or supplements, receiving any changes in diet or daily exercise programs
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Lahore Teaching Hospital
Lahore, Punjab Province, 54000, Pakistan
Related Publications (1)
Taghizadeh M, Memarzadeh MR, Abedi F, Sharifi N, Karamali F, Fakhrieh Kashan Z, Asemi Z. The Effect of Cumin cyminum L. Plus Lime Administration on Weight Loss and Metabolic Status in Overweight Subjects: A Randomized Double-Blind Placebo-Controlled Clinical Trial. Iran Red Crescent Med J. 2016 May 23;18(8):e34212. doi: 10.5812/ircmj.34212. eCollection 2016 Aug.
PMID: 27781121BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Maria Aslam
University of Lahore
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, CARE PROVIDER
- Masking Details
- Double- Blinded
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Maria Aslam
Study Record Dates
First Submitted
December 6, 2024
First Posted
December 11, 2024
Study Start
March 7, 2021
Primary Completion
July 11, 2021
Study Completion
November 20, 2021
Last Updated
December 16, 2024
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will not share
Data will be shared in the form of research articles without the personal information of the participant